Negative regulatory receptors of the IL-1 family.

[1]  A. Chalaris,et al.  Mouse neutrophils express the decoy type 2 interleukin‐1 receptor (IL‐1R2) constitutively and in acute inflammatory conditions , 2013, Journal of leukocyte biology.

[2]  C. Garlanda,et al.  Toll IL-1R8/Single Ig IL-1–Related Receptor Regulates Psoriasiform Inflammation through Direct Inhibition of Innate IL-17A Expression by γδ T Cells , 2013, The Journal of Immunology.

[3]  C. Garlanda,et al.  Absence of Toll-IL-1 receptor 8/single immunoglobulin IL-1 receptor-related molecule reduces house dust mite-induced allergic airway inflammation in mice. , 2013, American journal of respiratory cell and molecular biology.

[4]  M. Stahl,et al.  SIGIRR, a Negative Regulator of TLR/IL-1R Signalling Promotes Microbiota Dependent Resistance to Colonization by Enteric Bacterial Pathogens , 2013, PLoS pathogens.

[5]  M. Netea,et al.  New Insights in the Immunobiology of IL-1 Family Members , 2013, Front. Immunol..

[6]  Gang Li,et al.  Hydrodynamics-based delivery of an interleukin-1 receptor II fusion gene ameliorates rat autoimmune myocarditis by inhibiting IL-1 and Th17 cell polarization. , 2013, International journal of molecular medicine.

[7]  M. Bennett,et al.  Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation , 2013, Immunity.

[8]  N. Harir,et al.  Soluble human IL-1 receptor type 2 inhibits ectopic endometrial tissue implantation and growth: identification of a novel potential target for endometriosis treatment. , 2012, The American journal of pathology.

[9]  M. Inaba,et al.  Fetal thymus graft prevents age-related hearing loss and up regulation of the IL-1 receptor type II gene in CD4+ T cells , 2012, Journal of Neuroimmunology.

[10]  Zhanguo Li,et al.  The Largely Normal Response to Toll-Like Receptor 7 and 9 Stimulation and the Enhanced Expression of SIGIRR by B Cells in Systemic Lupus Erythematosus , 2012, PloS one.

[11]  S. Florquin,et al.  The Toll Interleukin-1 Receptor (IL-1R) 8/Single Ig Domain IL-1R-Related Molecule Modulates the Renal Response to Bacterial Infection , 2012, Infection and Immunity.

[12]  Hoon Kim,et al.  The Association Between Endometriosis and Polymorphisms in the Interleukin‐1 Family Genes in Korean Women , 2012, American journal of reproductive immunology.

[13]  Jos W. M. van der Meer,et al.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases , 2012, Nature Reviews Drug Discovery.

[14]  L. Hazlett,et al.  Vasoactive Intestinal Peptide Downregulates Proinflammatory TLRs While Upregulating Anti-Inflammatory TLRs in the Infected Cornea , 2012, The Journal of Immunology.

[15]  N. Young,et al.  Description of an Atlantic salmon (Salmo salar L.) type II interleukin-1 receptor cDNA and analysis of interleukin-1 receptor expression in amoebic gill disease-affected fish. , 2012, Fish & shellfish immunology.

[16]  T. Poon,et al.  Immunoregulatory Protein Profiles of Necrotizing Enterocolitis versus Spontaneous Intestinal Perforation in Preterm Infants , 2012, PloS one.

[17]  Tadao Saito,et al.  Immunobiotic Lactobacillus jensenii Modulates the Toll-Like Receptor 4-Induced Inflammatory Response via Negative Regulation in Porcine Antigen-Presenting Cells , 2012, Clinical and Vaccine Immunology.

[18]  J. Scheller,et al.  The membrane‐proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin‐6 receptor and interleukin‐1 receptor II , 2012, FEBS letters.

[19]  J. Farrar,et al.  Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. , 2012, The Journal of infectious diseases.

[20]  C. Garlanda,et al.  Role of Toll Interleukin-1 Receptor (IL-1R) 8, a Negative Regulator of IL-1R/Toll-Like Receptor Signaling, in Resistance to Acute Pseudomonas aeruginosa Lung Infection , 2011, Infection and Immunity.

[21]  L. French,et al.  Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression , 2011, Proceedings of the National Academy of Sciences.

[22]  Yuni Fang,et al.  Discovery of the DIGIRR Gene from Teleost Fish: A Novel Toll–IL-1 Receptor Family Member Serving as a Negative Regulator of IL-1 Signaling , 2011, The Journal of Immunology.

[23]  F. Civeira,et al.  Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions. , 2011, Biochimica et biophysica acta.

[24]  C. Garlanda,et al.  Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. , 2011, Blood.

[25]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[26]  R. Uauy,et al.  The Mechanism of Excessive Intestinal Inflammation in Necrotizing Enterocolitis: An Immature Innate Immune Response , 2011, PloS one.

[27]  M. Lynch,et al.  Interleukin-1α and HMGB1 Mediate Hippocampal Dysfunction in SIGIRR-Deficient Mice , 2011, The Journal of Neuroscience.

[28]  L. O’Neill,et al.  MicroRNAs: the fine-tuners of Toll-like receptor signalling , 2011, Nature Reviews Immunology.

[29]  Y. Ainmelk,et al.  Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin‐1 receptor II: To a link between endometriosis and endometrioid ovarian cancer , 2011, The journal of obstetrics and gynaecology research.

[30]  G. Qian,et al.  Enhanced Expression of Single Immunoglobulin IL-1 Receptor-Related Molecule Ameliorates LPS-Induced Acute Lung Injury in Mice , 2011, Shock.

[31]  L. Ivashkiv,et al.  Suppression of TNF-α and IL-1 Signaling Identifies a Mechanism of Homeostatic Regulation of Macrophages by IL-27 , 2010, The Journal of Immunology.

[32]  Stavroula Ntoufa,et al.  Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients , 2011, Haematologica.

[33]  F. Shanahan,et al.  Differential regulation of Toll‐like receptor signalling in spleen and Peyer’s patch dendritic cells , 2010, Immunology.

[34]  L. Joosten,et al.  IL-1 family nomenclature , 2010, Nature Immunology.

[35]  S. Ishihara,et al.  Down‐regulation of single immunoglobulin interleukin‐1R‐related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation , 2010, Clinical and experimental immunology.

[36]  Xi Liu,et al.  Structural insights into the assembly and activation of IL-1β with its receptors , 2010, Nature Immunology.

[37]  C. Pilarsky,et al.  Examination of Apoptosis Signaling in Pancreatic Cancer by Computational Signal Transduction Analysis , 2010, PloS one.

[38]  D. Drevets,et al.  Severe Listeria monocytogenes Infection Induces Development of Monocytes with Distinct Phenotypic and Functional Features , 2010, The Journal of Immunology.

[39]  M. Lynch,et al.  SIGIRR modulates the inflammatory response in the brain , 2010, Brain, Behavior, and Immunity.

[40]  K. Jacobson,et al.  Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice. , 2010, Gastroenterology.

[41]  C. Garlanda,et al.  SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[42]  C. Garlanda,et al.  Lack of SIGIRR/TIR8 aggravates hydrocarbon oil‐induced lupus nephritis , 2010, The Journal of pathology.

[43]  Shaila C. Rössle,et al.  Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach. , 2010, Journal of structural biology.

[44]  I. McInnes,et al.  Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.

[45]  V. Tuohy,et al.  The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. , 2010, Immunity.

[46]  Dana Kilroy,et al.  Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity. , 2010, European journal of pharmacology.

[47]  D. Unutmaz,et al.  Expression and Function of TNF and IL-1 Receptors on Human Regulatory T Cells , 2010, PloS one.

[48]  G. Remuzzi,et al.  The Toll-IL-1R Member Tir8/SIGIRR Negatively Regulates Adaptive Immunity against Kidney Grafts1 , 2009, The Journal of Immunology.

[49]  C. Garlanda,et al.  The expression pattern of TIR8 is conserved among vertebrates. , 2009, Veterinary immunology and immunopathology.

[50]  C. Garlanda,et al.  Resident Dendritic Cells Prevent Postischemic Acute Renal Failure by Help of Single Ig IL-1 Receptor-Related Protein1 , 2009, The Journal of Immunology.

[51]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[52]  G. Illei,et al.  Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. , 2009, Blood.

[53]  V. Bonagura,et al.  Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED , 2009, PloS one.

[54]  Xia Li,et al.  The Essential Role of Single Ig IL-1 Receptor-Related Molecule/Toll IL-1R8 in Regulation of Th2 Immune Response1 , 2009, The Journal of Immunology.

[55]  F. Nicoletti,et al.  The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy , 2009, Journal of Neuroimmunology.

[56]  Paolo Ghia,et al.  Expression and function of toll like receptors in chronic lymphocytic leukaemia cells , 2009, British journal of haematology.

[57]  L. O’Neill,et al.  The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress , 2008, Immunological reviews.

[58]  R. Gopal,et al.  Regulation of toll‐like receptors in intestinal epithelial cells by stress and Toxoplasma gondii infection , 2008, Parasite immunology.

[59]  C. Garlanda,et al.  Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens , 2008, The Journal of experimental medicine.

[60]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[61]  A. Lemay,et al.  Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain. , 2008, Fertility and sterility.

[62]  C. Gabay,et al.  IL‐1, IL‐18, and IL‐33 families of cytokines , 2008, Immunological reviews.

[63]  M. Lynch,et al.  IL‐1F5 mediates anti‐inflammatory activity in the brain through induction of IL‐4 following interaction with SIGIRR/TIR8 , 2008, Journal of neurochemistry.

[64]  L. Boon,et al.  Lack of Toll IL-1R8 Exacerbates Th17 Cell Responses in Fungal Infection1 , 2008, The Journal of Immunology.

[65]  O. Sheils,et al.  An integrative model for recurrence in ovarian cancer , 2008, Molecular Cancer.

[66]  C. Rao,et al.  Chorionic gonadotropin down-regulates the expression of the decoy inhibitory interleukin 1 receptor type II in human endometrial epithelial cells. , 2007, Endocrinology.

[67]  C. Garlanda,et al.  Damping Excessive Inflammation and Tissue Damage in Mycobacterium tuberculosis Infection by Toll IL-1 Receptor 8/Single Ig IL-1-Related Receptor, a Negative Regulator of IL-1/TLR Signaling1 , 2007, The Journal of Immunology.

[68]  C. Svanborg,et al.  Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. , 2007, The Journal of infectious diseases.

[69]  A. Mantovani,et al.  Different roles of TiR8/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells. , 2007, Kidney international.

[70]  C. Garlanda,et al.  Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. , 2007, Cancer research.

[71]  J. Heersche,et al.  Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases , 2007, Journal of cellular biochemistry.

[72]  C. A. de la Motte,et al.  The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. , 2007, Immunity.

[73]  B. de Strooper,et al.  Regulated Intramembrane Proteolysis of the Interleukin-1 Receptor II by α-, β-, and γ-Secretase* , 2007, Journal of Biological Chemistry.

[74]  L. V. von Segesser,et al.  Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[75]  U. Andersson,et al.  Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. , 2007, Arthritis and rheumatism.

[76]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[77]  N. Kamatani,et al.  Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts , 2006, Proceedings of the National Academy of Sciences.

[78]  L. Hazlett,et al.  SIGIRR Promotes Resistance against Pseudomonas aeruginosa Keratitis by Down-Regulating Type-1 Immunity and IL-1R1 and TLR4 Signaling1 , 2006, The Journal of Immunology.

[79]  V. Nizet,et al.  Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer , 2006, Cell.

[80]  Xiaoxia Li,et al.  SIGIRR Inhibits Interleukin-1 Receptor- and Toll-like Receptor 4-mediated Signaling through Different Mechanisms* , 2005, Journal of Biological Chemistry.

[81]  S. Nishiguchi,et al.  Evolution of interleukin-18 binding proteins and interleukin-1 receptor, type II proteins. , 2005, International journal of molecular medicine.

[82]  V. Perry,et al.  Differential regulation of type I and type II interleukin‐1 receptors in focal brain inflammation , 2005, The European journal of neuroscience.

[83]  G. Trinchieri,et al.  Human TLR10 Is a Functional Receptor, Expressed by B Cells and Plasmacytoid Dendritic Cells, Which Activates Gene Transcription through MyD881 , 2005, The Journal of Immunology.

[84]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[85]  J. Sims,et al.  Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs* , 2004, Journal of Biological Chemistry.

[86]  F. Bethencourt,et al.  Interleukin‐1 (IL‐1α and IL‐1β) and its receptors (IL‐1RI, IL‐1RII, and IL‐1Ra) in prostate carcinoma , 2004 .

[87]  C. Garlanda,et al.  Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Feras Hawari,et al.  Shedding of the Type II IL-1 Decoy Receptor Requires a Multifunctional Aminopeptidase, Aminopeptidase Regulator of TNF Receptor Type 1 Shedding , 2003, The Journal of Immunology.

[89]  C. Garlanda,et al.  Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. , 2003, European cytokine network.

[90]  G. Stark,et al.  SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling , 2003, Nature Immunology.

[91]  J. Tschopp,et al.  MyD88S, a splice variant of MyD88, differentially modulates NF‐κB‐ and AP‐1‐dependent gene expression , 2003, FEBS letters.

[92]  Ruslan Medzhitov,et al.  Toll-Like Receptor Signaling Pathways , 2003, Science.

[93]  N. Rothwell,et al.  Expression of interleukin‐1 receptors and their role in interleukin‐1 actions in murine microglial cells , 2002, Journal of neurochemistry.

[94]  A. Mantovani,et al.  High circulating levels of the IL‐1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration , 2002, Journal of leukocyte biology.

[95]  C. Jolicoeur,et al.  Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis. , 2001, The American journal of pathology.

[96]  S. Abramson,et al.  Reversal of Autocrine and Paracrine Effects of Interleukin 1 (IL-1) in Human Arthritis by Type II IL-1 Decoy Receptor , 2000, The Journal of Biological Chemistry.

[97]  Dirk E. Smith,et al.  Identification and Characterization of Two Members of a Novel Class of the Interleukin-1 Receptor (IL-1R) Family , 2000, The Journal of Biological Chemistry.

[98]  Antonio Alcami,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[99]  A. Whitehead,et al.  IL-1 Signaling Cascade in Liver Cells and the Involvement of a Soluble Form of the IL-1 Receptor Accessory Protein1 2 , 2000, The Journal of Immunology.

[100]  A. Mantovani,et al.  The type II decoy receptor of IL‐1 inhibits murine collagen‐induced arthritis , 2000, European journal of immunology.

[101]  R. W. Ball,et al.  Aspirin‐induced increases in soluble IL‐1 receptor type II concentrations in vitro and in vivo , 1999, Journal of leukocyte biology.

[102]  J. Sims,et al.  Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. , 1999, Cytokine.

[103]  P. Ramage,et al.  Effects of soluble interleukin-1 type II receptor on rabbit antigen-induced arthritis: clinical, biochemical and histological assessment. , 1999, Rheumatology.

[104]  H. Basun,et al.  Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients , 1999, Brain Research.

[105]  A. Mantovani,et al.  Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. , 1999, Journal of immunology.

[106]  D. Boraschi,et al.  The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. , 1998, Journal of immunology.

[107]  T. Bártfai,et al.  Interleukin‐1 receptor accessory protein interacts with the type II interleukin‐1 receptor , 1998, FEBS letters.

[108]  T. Bártfai,et al.  Human/mouse interleukin‐1 receptor/receptor accessory protein interactions in IL‐1β‐induced NFκB activation , 1998 .

[109]  C. Dinarello,et al.  Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction. , 1998, Arthritis and rheumatism.

[110]  H. Dickensheets,et al.  IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes. , 1997, Journal of immunology.

[111]  A. H. Drummond,et al.  Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor* , 1997, The Journal of Biological Chemistry.

[112]  T. Kupper,et al.  Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[113]  A. Mantovani,et al.  TNF-alpha, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. , 1997, Journal of immunology.

[114]  J. Prins,et al.  The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. , 1997, Journal of immunology.

[115]  William Clevenger,et al.  Cloning and Characterization of an Alternatively Processed Human Type II Interleukin-1 Receptor mRNA* , 1996, The Journal of Biological Chemistry.

[116]  S. Saccani,et al.  Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. , 1996, Journal of immunology.

[117]  A. Mantovani,et al.  Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function , 1996, The Journal of experimental medicine.

[118]  A. Mantovani,et al.  Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells , 1995, The Journal of experimental medicine.

[119]  P. Young,et al.  Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[120]  S. Dower,et al.  Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. , 1994, Journal of immunology.

[121]  A. Mantovani,et al.  Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. , 1994, The Journal of biological chemistry.

[122]  A. Mantovani,et al.  The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor , 1994, The Journal of experimental medicine.

[123]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[124]  S. Dower,et al.  Molecular characterization of the interleukin-1 receptor (IL-1R) on monocytes and polymorphonuclear cells. , 1992, Cytokine.

[125]  K. Huebner,et al.  A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. , 1991, The EMBO journal.

[126]  P. Gregersen,et al.  Microarray Analyses of Peripheral Blood Cells Identifies Unique Gene Expression Signature in Psoriatic Arthritis , 2005, Molecular medicine.

[127]  Dirk E. Smith,et al.  The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. , 2003, Immunity.

[128]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.

[129]  C. Croce,et al.  Chromosomal location of murine and human IL-1 receptor genes. , 1991, Genomics.